Advanced search
Publication Cover
Current Medical Research and Opinion Volume 36, 2020 - Issue 4
Submit an article Journal homepage
2,100
Views
5
CrossRef citations to date
0
Altmetric
Cardiovascular Medicine

Healthcare resource utilization and costs among nonvalvular atrial fibrillation patients initiating rivaroxaban or warfarin in skilled nursing facilities: a retrospective cohort study

V. Simon Mittala Advanced Health Institute and LTC Professionals, Bloomington, MN, USACorrespondence[email protected]
,
Bingcao Wub Janssen Scientific Affairs, LLC, Titusville, NJ, USA
,
Ji Songb Janssen Scientific Affairs, LLC, Titusville, NJ, USA
,
Dejan Milentijevicb Janssen Scientific Affairs, LLC, Titusville, NJ, USA
,
Veronica Ashtonb Janssen Scientific Affairs, LLC, Titusville, NJ, USA
&
Dheeraj Mahajanc University of Illinois at Chicago and Advocate Illinois Masonic Medical Center, Melrose Park, IL, USA
Pages 529-536 | Received 08 Nov 2019, Accepted 16 Dec 2019, Published online: 09 Jan 2020

References

  • Rich MW. Atrial fibrillation in long term care. J Am Med Dir Assoc. 2012;13(8):688–691.
  • Morin DP, Bernard ML, Madias C, et al. The state of the art: atrial fibrillation epidemiology, prevention, and treatment. Mayo Clin Proc. 2016;91(12):1778–1810.
  • Colilla S, Crow A, Petkun W, et al. Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. Am J Cardiol. 2013;112(8):1142–1147.
  • Centers for Disease Control and Prevention [Internet]. Atrial fibrillation fact sheet. 2017 [cited 2019 Jan 23]. Available from: https://www.cdc.gov/dhdsp/data_statistics/fact_sheets/fs_atrial_fibrillation.htm.
  • Rahman F, Kwan GF, Benjamin EJ. Global epidemiology of atrial fibrillation. Nat Rev Cardiol. 2014;11(11):639–654.
  • Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22(8):983–988.
  • National Stroke Association [Internet]. AFib-stroke connection. 2018 [cited 2019 Feb 25]. Available from: https://www.stroke.org/understand-stroke/preventing-a-stroke/afib-stroke-connection/.
  • Ekerstad N, Karlsson T, Soderqvist S, et al. Hospitalized frail elderly patients – atrial fibrillation, anticoagulation and 12 months’ outcomes. Clin Interv Aging. 2018;13:749–756.
  • January CT, Wann LS, Calkins H, et al. AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2019;74(1):104–132.
  • Patel MR, Mahaffey KW, the ROCKET AF Steering Committee, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365(10):883–891.
  • Beyer-Westendorf J, Camm AJ, Coleman CI, et al. Rivaroxaban real-world evidence: validating safety and effectiveness in clinical practice. Thromb Haemost. 2016;116(suppl 2):S13–S23.
  • Austin PC, Stuart EA. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Statist Med. 2015;34(28):3661–3679.
  • Brookhart MA, Wyss R, Layton JB, et al. Propensity score methods for confounding control in nonexperimental research. Circ Cardiovasc Qual Outcomes. 2013;6(5):604–611.
  • Gurwitz JH, Field TS, Radford MJ, et al. The safety of warfarin therapy in the nursing home setting. Am J Med. 2007;120(6):539–544.
  • Patel AA, Nelson WW. Nurses’ self-reported time estimation of anticoagulation therapy: a survey of warfarin management in long-term care. BMC Nurs. 2015;14(1):8.
  • Reardon G, Patel AA, Nelson WW, et al. Usage of medications with high potential to interact with warfarin among atrial fibrillation residents in long-term care facilities. Expert Opin Pharmacother. 2013;14(2):165–173.
  • Verhovsek M, Motlagh B, Crowther MA, et al. Quality of anticoagulation and use of warfarin-interacting medications in long-term care: a chart review. BMC Geriatr. 2008;8(1):13.
  • Reardon G, Nelson WW, Patel AA, et al. Warfarin for prevention of thrombosis among long-term care residents with atrial fibrillation: evidence of continuing low use despite consideration of stroke and bleeding risk. Drugs Aging. 2013;30(6):417–428.
  • Neidecker M, Patel AA, Nelson WW, et al. Use of warfarin in long-term care: a systematic review. BMC Geriatr. 2012;12(1):14.
  • Ghaswalla PK, Harpe SE, Slattum PW. Warfarin use in nursing home residents: results from the 2004 national nursing home survey. Am J Geriatr Pharmacother. 2012;10(1):25–36 e22.
  • Alcusky M, Lapane KL. Treatment of atrial fibrillation in nursing homes: a place for direct acting oral anticoagulants? J Nurs Home Res Sci. 2018;4:15–19.
  • Sommerauer C, Schlender L, Krause M, et al. Effectiveness and safety of vitamin K antagonists and new anticoagulants in the prevention of thromboembolism in atrial fibrillation in older adults – a systematic review of reviews and the development of recommendations to reduce inappropriate prescribing. BMC Geriatr. 2017;17(S1):223.
  • Steinberg BA, Shrader P, Thomas L, et al. Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II). Am Heart J. 2017;189:40–47.
  • American Health Care Association [Internet]. SNF value-based purchasing (SNF VBP). 2017 [cited 2019 Apr 2]. Available from: https://www.ahcancal.org/facility_operations/Pages/SNF-Value-Based-Purchasing.aspx.
  • Castellucci M [Internet]. Most skilled-nursing facilities penalized by CMS for readmission rates. 2018 [cited 2019 Apr 2]; Available from: https://www.modernhealthcare.com/article/20181128/NEWS/181129930/most-skilled-nursing-facilities-penalized-by-cms-for-readmission-rates.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.